Cardiovascular Diseases Clinical Trial
Official title:
Impact of Lifestyle Modification on Prevention of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population: Cluster Randomized Controlled Trial
This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani.
This is a community-based cluster randomized control trial aimed to investigate the impact
of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the
development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive
pulmonary disease and cardiovascular disease in an intermediate risk population in mixed
urban-rural areas of Ubon Ratchathani.
Objectives:
1. examine the impact of lifestyle modification on the development of dementia, diabetes,
chronic kidney disease, cancers, chronic obstructive pulmonary disease and
cardiovascular disease in an intermediate risk population in Ubon Ratchathani
2. examine the economic impact of lifestyle modification on prevention of dementia,
diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and
cardiovascular disease in an intermediate risk population in Ubon Ratchathani
Study design: community-based cluster randomized control trial
Setting: 60 villages randomly selected from mixed urban-rural areas in 15 districts of Ubon
Ratchathani province.
Study population: 3,600 apparently healthy men and women aged 45-75 years who have resided
in the village selected for at least one year. 4,000 men and women will be approached and
screened.
Screening and baseline assessment:
After community consent, potential participants will be informed about the details of the
project. For those who are willing to participate, written informed consent will be given
before carrying out all research procedures. Participants will be questioned about their
demographic characteristics, medical and family history, health behaviours including diet,
physical activity, alcohol drinking and smoking. Physical activity will be assess using the
Global Physical Activity Questionnaire (GPAQ) and diet will be assessed using 24 hour food
recall. Their cognitive function will be assessed using the Mini-Mental State Exam (MMSE),
Thai version, and clock drawing test and depression test will also be performed. Physical
examination includes weight, height, blood pressure, waist and hip circumference as well as
physical fitness test.
Fasting blood samples will be collected for the following laboratory tests: Complete blood
count, creatinine, estimated glomerular filtration rate (eGFR), fasting plasma glucose,
glycated haemoglobin (HbA1c), total cholesterol, triglyceride, HDL and estimated
LDL-cholesterol, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic
transaminase (SGPT), thyroid stimulating hormone (TSH), Ca++, PO4-, urine
creatinine/albumin, urine sodium & potassium.
Interventions:
Participants in 30 villages in the intervention group will be given 4x4 lifestyle
modification intervention, which will address four health behaviors (diet, physical
activity, alcohol drinking and smoking) at four different levels: individual, household,
knowledge management and community levels. A new computer program called 'iActive' will be
used. The program was adapted from the GPAQ with add-on functions to allow real-time
assessment and presentation of the energy expenditure along with recommendations specific to
each individual. Dietary counseling will be given individually following assessment using a
new dietary assessment program called Dietary Assessment Scanning Calculator (DISC). Home
visit will be done every 3 months by responsible nurses and village health volunteers in
order to assess and give simple counseling about health behaviors. Knowledge management will
be undertaken through meetings and forums between participants and villages with support
from trained nurses. Situation analysis and agreed community action will be encouraged to
address community problems concerning four health behaviors. A combination of these
intensive interventions will be given for 3 years.
Follow-up and outcome ascertainment:
Participants will be followed at 1, 2, 5 and 10 years after baseline assessment for the
development of the outcomes of interest. In each follow-up, procedures identical to baseline
assessment will be done.
Primary outcome: Incident dementia Incident dementia will be ascertained by a battery of
screening test (MMSE, clock drawing and depression tests) and those with abnormal test
results will be referred to neuro-medicine specialists at the regional hospital for further
investigations and diagnosis.
Secondary outcomes:
1. Type 2 diabetes mellitus
2. chronic kidney disease
3. cancers
4. chronic obstructive pulmonary disease
5. cardiovascular disease
6. body mass index
7. waist circumference
8. blood pressure
9. Fasting plasma glucose
10. HbA1c
11. Lipids (total cholesterol, triglyceride, HDL and estimated LDL)
Tertiary outcomes:
1. MMSE scores or Cognitive decline
2. Alzheimer's disease
3. Physical activity levels
4. Dietary intake
5. prevalence of current smokers
6. prevalence of alcohol consumption
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|